ReP USP - Resultado da busca

Artigo de periodico
Bipolar symptoms, somatic burden, and functioning in older-age bipolar disorder: analyses from the Global Aging & Geriatric Experiments in Bipolar Disorder Database project (2022)
Sajatovic, Martha; Dols, Annemiek; Rej, Soham; Almeida, Osvaldo P; Beunders, Alexandra J. M; Blumberg, Hilary P; Briggs, Farren B. S; Forester, Brent P; Patrick, Regan E; Forlenza, Orestes Vicente
Source: Bipolar disorders. Unidade: FM
Subjects: TRANSTORNO BIPOLAR, COMPORTAMENTO, COMORBIDADE, DEPRESSÃO, ESTUDOS DE COORTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAJATOVIC, Martha et al. Bipolar symptoms, somatic burden, and functioning in older-age bipolar disorder: analyses from the Global Aging & Geriatric Experiments in Bipolar Disorder Database project. Bipolar disorders, v. 24, n. 2, p. 195-206, 2022Tradução . . Disponível em: https://doi.org/10.1111/bdi.13119. Acesso em: 06 jun. 2024.
APA
Sajatovic, M., Dols, A., Rej, S., Almeida, O. P., Beunders, A. J. M., Blumberg, H. P., et al. (2022). Bipolar symptoms, somatic burden, and functioning in older-age bipolar disorder: analyses from the Global Aging & Geriatric Experiments in Bipolar Disorder Database project. Bipolar disorders, 24( 2), 195-206. doi:10.1111/bdi.13119
NLM
Sajatovic M, Dols A, Rej S, Almeida OP, Beunders AJM, Blumberg HP, Briggs FBS, Forester BP, Patrick RE, Forlenza OV. Bipolar symptoms, somatic burden, and functioning in older-age bipolar disorder: analyses from the Global Aging & Geriatric Experiments in Bipolar Disorder Database project [Internet]. Bipolar disorders. 2022 ; 24( 2): 195-206.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1111/bdi.13119
Vancouver
Sajatovic M, Dols A, Rej S, Almeida OP, Beunders AJM, Blumberg HP, Briggs FBS, Forester BP, Patrick RE, Forlenza OV. Bipolar symptoms, somatic burden, and functioning in older-age bipolar disorder: analyses from the Global Aging & Geriatric Experiments in Bipolar Disorder Database project [Internet]. Bipolar disorders. 2022 ; 24( 2): 195-206.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1111/bdi.13119
Artigo de periodico
Repetitive transcranial magnetic stimulation for major depressive disorder in older adults: systematic review and meta-analysis (2022)
Valiengo, Leandro; Maia, Ana; Cotovio, Goncalo; Gordon, Pedro C; Brunoni, Andre Russowsky ; Forlenza, Orestes Vicente ; Oliveira-maia, Albino J
Source: Journals of gerontology series a-biological sciences and medical sciences. Unidade: FM
Subjects: REVISÃO SISTEMÁTICA, ESTIMULAÇÃO MAGNÉTICA TRANSCRANIANA, DEPRESSÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VALIENGO, Leandro et al. Repetitive transcranial magnetic stimulation for major depressive disorder in older adults: systematic review and meta-analysis. Journals of gerontology series a-biological sciences and medical sciences, v. 77, n. 4, p. 851-860, 2022Tradução . . Disponível em: https://doi.org/10.1093/gerona/glab235. Acesso em: 06 jun. 2024.
APA
Valiengo, L., Maia, A., Cotovio, G., Gordon, P. C., Brunoni, A. R., Forlenza, O. V., & Oliveira-maia, A. J. (2022). Repetitive transcranial magnetic stimulation for major depressive disorder in older adults: systematic review and meta-analysis. Journals of gerontology series a-biological sciences and medical sciences, 77( 4), 851-860. doi:10.1093/gerona/glab235
NLM
Valiengo L, Maia A, Cotovio G, Gordon PC, Brunoni AR, Forlenza OV, Oliveira-maia AJ. Repetitive transcranial magnetic stimulation for major depressive disorder in older adults: systematic review and meta-analysis [Internet]. Journals of gerontology series a-biological sciences and medical sciences. 2022 ; 77( 4): 851-860.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1093/gerona/glab235
Vancouver
Valiengo L, Maia A, Cotovio G, Gordon PC, Brunoni AR, Forlenza OV, Oliveira-maia AJ. Repetitive transcranial magnetic stimulation for major depressive disorder in older adults: systematic review and meta-analysis [Internet]. Journals of gerontology series a-biological sciences and medical sciences. 2022 ; 77( 4): 851-860.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1093/gerona/glab235
Artigo de periodico
The role of lithium treatment on comorbid anxiety symptoms in patients with bipolar depression (2022)
Jones, Gregory; Rong, Carola; Vecera, Courtney M; Gurguis, Christopher I; Chudal, Roshan; Khairova, Rushaniya; Leung, Edison; Ruiz, Ana C; Busatto Filho, Geraldo ; Gattaz, Wagner Farid
Source: Journal of affective disorders. Unidade: FM
Subjects: LÍTIO, ANSIEDADE, DEPRESSÃO, SINAIS E SINTOMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JONES, Gregory et al. The role of lithium treatment on comorbid anxiety symptoms in patients with bipolar depression. Journal of affective disorders, v. 308, p. 71-75, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.jad.2022.04.025. Acesso em: 06 jun. 2024.
APA
Jones, G., Rong, C., Vecera, C. M., Gurguis, C. I., Chudal, R., Khairova, R., et al. (2022). The role of lithium treatment on comorbid anxiety symptoms in patients with bipolar depression. Journal of affective disorders, 308, 71-75. doi:10.1016/j.jad.2022.04.025
NLM
Jones G, Rong C, Vecera CM, Gurguis CI, Chudal R, Khairova R, Leung E, Ruiz AC, Busatto Filho G, Gattaz WF. The role of lithium treatment on comorbid anxiety symptoms in patients with bipolar depression [Internet]. Journal of affective disorders. 2022 ; 308 71-75.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1016/j.jad.2022.04.025
Vancouver
Jones G, Rong C, Vecera CM, Gurguis CI, Chudal R, Khairova R, Leung E, Ruiz AC, Busatto Filho G, Gattaz WF. The role of lithium treatment on comorbid anxiety symptoms in patients with bipolar depression [Internet]. Journal of affective disorders. 2022 ; 308 71-75.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1016/j.jad.2022.04.025
Artigo de periodico
Lithium increases cortical and subcortical volumes in subjects with bipolar disorder (2022)
Jones, Gregory; Suchting, Robert; Zanetti, Marcus V; Leung, Edison; Costa, Sabrina Correa da; Sousa, Rafael T. de; Busatto Filho, Geraldo ; Soares, Jair; Otaduy, Maria C; Gattaz, Wagner Farid ; Machado-Vieira, Rodrigo
Source: Psychiatry research-neuroimaging. Unidade: FM
Subjects: SAÚDE MENTAL, TRANSTORNO BIPOLAR, CÓRTEX CEREBRAL, IMAGEM POR RESSONÂNCIA MAGNÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JONES, Gregory et al. Lithium increases cortical and subcortical volumes in subjects with bipolar disorder. Psychiatry research-neuroimaging, v. 324, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.pscychresns.2022.111494. Acesso em: 06 jun. 2024.
APA
Jones, G., Suchting, R., Zanetti, M. V., Leung, E., Costa, S. C. da, Sousa, R. T. de, et al. (2022). Lithium increases cortical and subcortical volumes in subjects with bipolar disorder. Psychiatry research-neuroimaging, 324. doi:10.1016/j.pscychresns.2022.111494
NLM
Jones G, Suchting R, Zanetti MV, Leung E, Costa SC da, Sousa RT de, Busatto Filho G, Soares J, Otaduy MC, Gattaz WF, Machado-Vieira R. Lithium increases cortical and subcortical volumes in subjects with bipolar disorder [Internet]. Psychiatry research-neuroimaging. 2022 ; 324[citado 2024 jun. 06 ] Available from: https://doi.org/10.1016/j.pscychresns.2022.111494
Vancouver
Jones G, Suchting R, Zanetti MV, Leung E, Costa SC da, Sousa RT de, Busatto Filho G, Soares J, Otaduy MC, Gattaz WF, Machado-Vieira R. Lithium increases cortical and subcortical volumes in subjects with bipolar disorder [Internet]. Psychiatry research-neuroimaging. 2022 ; 324[citado 2024 jun. 06 ] Available from: https://doi.org/10.1016/j.pscychresns.2022.111494
Artigo de periodico
Neuropsychiatric symptoms and cerebrovascular risk in non-demented elders: cross-sectional study using the mild behavioural impairment checklist (MBI-C) (2022)
Stella, Florindo; Pais, Marcos V; Loureiro, Julia C; Radanovic, Marcia; Forlenza, Orestes Vicente
Source: Psychogeriatrics. Unidade: FM
Subjects: DOENÇA DE ALZHEIMER, SINAIS E SINTOMAS, NEUROIMAGEM, DIAGNÓSTICO POR IMAGEM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
STELLA, Florindo et al. Neuropsychiatric symptoms and cerebrovascular risk in non-demented elders: cross-sectional study using the mild behavioural impairment checklist (MBI-C). Psychogeriatrics, v. 22, n. 1, p. 55-66, 2022Tradução . . Disponível em: https://doi.org/10.1111/psyg.12776. Acesso em: 06 jun. 2024.
APA
Stella, F., Pais, M. V., Loureiro, J. C., Radanovic, M., & Forlenza, O. V. (2022). Neuropsychiatric symptoms and cerebrovascular risk in non-demented elders: cross-sectional study using the mild behavioural impairment checklist (MBI-C). Psychogeriatrics, 22( 1), 55-66. doi:10.1111/psyg.12776
NLM
Stella F, Pais MV, Loureiro JC, Radanovic M, Forlenza OV. Neuropsychiatric symptoms and cerebrovascular risk in non-demented elders: cross-sectional study using the mild behavioural impairment checklist (MBI-C) [Internet]. Psychogeriatrics. 2022 ; 22( 1): 55-66.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1111/psyg.12776
Vancouver
Stella F, Pais MV, Loureiro JC, Radanovic M, Forlenza OV. Neuropsychiatric symptoms and cerebrovascular risk in non-demented elders: cross-sectional study using the mild behavioural impairment checklist (MBI-C) [Internet]. Psychogeriatrics. 2022 ; 22( 1): 55-66.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1111/psyg.12776
Artigo de periodico
Plxxuatic endocannabinoids are decreased in subjects with ultra-high risk of psychosis (2022)
Joaquim, Helena P. G; Costa, Alana C; Pereira, Cicero A. C; Talib, Leda L; Bilt, Martinus M. V; Loch, Alexandre A; Gattaz, Wagner Farid
Source: European journal of neuroscience. Unidade: FM
Subjects: PSICOSE EM ADULTO, CANABINOIDES, PSICOSE INFANTIL, FATORES DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JOAQUIM, Helena P. G et al. Plxxuatic endocannabinoids are decreased in subjects with ultra-high risk of psychosis. European journal of neuroscience, v. 55, n. 4, p. 1079-1087, 2022Tradução . . Disponível em: https://doi.org/10.1111/ejn.15509. Acesso em: 06 jun. 2024.
APA
Joaquim, H. P. G., Costa, A. C., Pereira, C. A. C., Talib, L. L., Bilt, M. M. V., Loch, A. A., & Gattaz, W. F. (2022). Plxxuatic endocannabinoids are decreased in subjects with ultra-high risk of psychosis. European journal of neuroscience, 55( 4), 1079-1087. doi:10.1111/ejn.15509
NLM
Joaquim HPG, Costa AC, Pereira CAC, Talib LL, Bilt MMV, Loch AA, Gattaz WF. Plxxuatic endocannabinoids are decreased in subjects with ultra-high risk of psychosis [Internet]. European journal of neuroscience. 2022 ; 55( 4): 1079-1087.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1111/ejn.15509
Vancouver
Joaquim HPG, Costa AC, Pereira CAC, Talib LL, Bilt MMV, Loch AA, Gattaz WF. Plxxuatic endocannabinoids are decreased in subjects with ultra-high risk of psychosis [Internet]. European journal of neuroscience. 2022 ; 55( 4): 1079-1087.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1111/ejn.15509
Artigo de periodico-carta/editorial
Impact of SARS-CoV-2 pandemic on mental health in the elderly. [Editorial]: perspective from a psychogeriatric clinic at a tertiary hospital in Sao Paulo, Brazil (2020)
Forlenza, Orestes Vicente ; Stella, Florindo
Source: International psychogeriatrics. Unidade: FM
Subjects: ENVELHECIMENTO, CONTROLE DE DOENÇAS TRANSMISSÍVEIS, PSIQUIATRIA GERIÁTRICA, PNEUMONIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FORLENZA, Orestes Vicente e STELLA, Florindo. Impact of SARS-CoV-2 pandemic on mental health in the elderly. [Editorial]: perspective from a psychogeriatric clinic at a tertiary hospital in Sao Paulo, Brazil. International psychogeriatrics. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1017/S1041610220001180. Acesso em: 06 jun. 2024. , 2020
APA
Forlenza, O. V., & Stella, F. (2020). Impact of SARS-CoV-2 pandemic on mental health in the elderly. [Editorial]: perspective from a psychogeriatric clinic at a tertiary hospital in Sao Paulo, Brazil. International psychogeriatrics. New York: Faculdade de Medicina, Universidade de São Paulo. doi:10.1017/S1041610220001180
NLM
Forlenza OV, Stella F. Impact of SARS-CoV-2 pandemic on mental health in the elderly. [Editorial]: perspective from a psychogeriatric clinic at a tertiary hospital in Sao Paulo, Brazil [Internet]. International psychogeriatrics. 2020 ; 32( 10): 1147-1151.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1017/S1041610220001180
Vancouver
Forlenza OV, Stella F. Impact of SARS-CoV-2 pandemic on mental health in the elderly. [Editorial]: perspective from a psychogeriatric clinic at a tertiary hospital in Sao Paulo, Brazil [Internet]. International psychogeriatrics. 2020 ; 32( 10): 1147-1151.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1017/S1041610220001180
Artigo de periodico
Passive antiamyloid immunotherapy for Alzheimer's disease (2020)
Loureiro, Julia C; Pais, Marcos V; Stella, Florindo; Radanovic, Marcia; Teixeira, Antonio Lucio; Forlenza, Orestes Vicente ; Souza, Leonardo Cruz de
Source: Current opinion in psychiatry. Unidade: FM
Subjects: IMUNIZAÇÃO PASSIVA, DOENÇA DE ALZHEIMER, ANTICORPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOUREIRO, Julia C et al. Passive antiamyloid immunotherapy for Alzheimer's disease. Current opinion in psychiatry, v. 33, n. 3, p. 284-291, 2020Tradução . . Disponível em: https://doi.org/10.1097/YCO.0000000000000587. Acesso em: 06 jun. 2024.
APA
Loureiro, J. C., Pais, M. V., Stella, F., Radanovic, M., Teixeira, A. L., Forlenza, O. V., & Souza, L. C. de. (2020). Passive antiamyloid immunotherapy for Alzheimer's disease. Current opinion in psychiatry, 33( 3), 284-291. doi:10.1097/YCO.0000000000000587
NLM
Loureiro JC, Pais MV, Stella F, Radanovic M, Teixeira AL, Forlenza OV, Souza LC de. Passive antiamyloid immunotherapy for Alzheimer's disease [Internet]. Current opinion in psychiatry. 2020 ; 33( 3): 284-291.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1097/YCO.0000000000000587
Vancouver
Loureiro JC, Pais MV, Stella F, Radanovic M, Teixeira AL, Forlenza OV, Souza LC de. Passive antiamyloid immunotherapy for Alzheimer's disease [Internet]. Current opinion in psychiatry. 2020 ; 33( 3): 284-291.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1097/YCO.0000000000000587
Artigo de periodico
Cognitive impairment in remitted late -life depression is not associated with Alzheimer's disease -related CSF biomarkers (2020)
Loureiro, Julia C; Stella, Florindo; Pais, Marcos V; Radanovic, Marcia; Canineu, Paulo R; Joaquim, Helena P. G; Talib, Leda L; Forlenza, Orestes Vicente
Source: Journal of affective disorders. Unidade: FM
Subjects: BIOMARCADORES, DEPRESSÃO, DOENÇA DE ALZHEIMER, LÍQUIDO CEFALORRAQUIDIANO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOUREIRO, Julia C et al. Cognitive impairment in remitted late -life depression is not associated with Alzheimer's disease -related CSF biomarkers. Journal of affective disorders, v. 272, p. 409-416, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jad.2020.03.166. Acesso em: 06 jun. 2024.
APA
Loureiro, J. C., Stella, F., Pais, M. V., Radanovic, M., Canineu, P. R., Joaquim, H. P. G., et al. (2020). Cognitive impairment in remitted late -life depression is not associated with Alzheimer's disease -related CSF biomarkers. Journal of affective disorders, 272, 409-416. doi:10.1016/j.jad.2020.03.166
NLM
Loureiro JC, Stella F, Pais MV, Radanovic M, Canineu PR, Joaquim HPG, Talib LL, Forlenza OV. Cognitive impairment in remitted late -life depression is not associated with Alzheimer's disease -related CSF biomarkers [Internet]. Journal of affective disorders. 2020 ; 272 409-416.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1016/j.jad.2020.03.166
Vancouver
Loureiro JC, Stella F, Pais MV, Radanovic M, Canineu PR, Joaquim HPG, Talib LL, Forlenza OV. Cognitive impairment in remitted late -life depression is not associated with Alzheimer's disease -related CSF biomarkers [Internet]. Journal of affective disorders. 2020 ; 272 409-416.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1016/j.jad.2020.03.166
Artigo de periodico-carta/editorial
Plasma metabolites in first episode psychoses [Carta] (2019)
Costa, Alana C; Joaquim, Helena P. G; Talib, Leda L; Serpa, Mauricio H; Zanetti, Marcus V; Gattaz, Wagner Farid
Source: Schizophrenia research. Unidade: FM
Subjects: BIOMARCADORES, ESQUIZOFRENIA, MANIFESTAÇÕES NEUROLÓGICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Alana C et al. Plasma metabolites in first episode psychoses [Carta]. Schizophrenia research. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.schres.2018.11.010. Acesso em: 06 jun. 2024. , 2019
APA
Costa, A. C., Joaquim, H. P. G., Talib, L. L., Serpa, M. H., Zanetti, M. V., & Gattaz, W. F. (2019). Plasma metabolites in first episode psychoses [Carta]. Schizophrenia research. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.schres.2018.11.010
NLM
Costa AC, Joaquim HPG, Talib LL, Serpa MH, Zanetti MV, Gattaz WF. Plasma metabolites in first episode psychoses [Carta] [Internet]. Schizophrenia research. 2019 ; 206 468-470.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1016/j.schres.2018.11.010
Vancouver
Costa AC, Joaquim HPG, Talib LL, Serpa MH, Zanetti MV, Gattaz WF. Plasma metabolites in first episode psychoses [Carta] [Internet]. Schizophrenia research. 2019 ; 206 468-470.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1016/j.schres.2018.11.010
Artigo de periodico
Kynurenine is correlated with IL-1 beta in plasma of schizophrenia patients (2018)
Joaquim, Helena P. G.; Costa, Alana C.; Gattaz, Wagner F.; Talib, Leda Leme
Source: Journal of neural transmission. Unidade: FM
Subjects: ESCALAS DE GRADUAÇÃO PSIQUIÁTRICA, PSICODIAGNÓSTICO, ESQUIZOFRENIA, INFLAMAÇÃO, CITOCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JOAQUIM, Helena P. G. et al. Kynurenine is correlated with IL-1 beta in plasma of schizophrenia patients. Journal of neural transmission, v. 125, n. 5, p. 869-873, 2018Tradução . . Disponível em: https://doi.org/10.1007/s00702-018-1838-8. Acesso em: 06 jun. 2024.
APA
Joaquim, H. P. G., Costa, A. C., Gattaz, W. F., & Talib, L. L. (2018). Kynurenine is correlated with IL-1 beta in plasma of schizophrenia patients. Journal of neural transmission, 125( 5), 869-873. doi:10.1007/s00702-018-1838-8
NLM
Joaquim HPG, Costa AC, Gattaz WF, Talib LL. Kynurenine is correlated with IL-1 beta in plasma of schizophrenia patients [Internet]. Journal of neural transmission. 2018 ; 125( 5): 869-873.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1007/s00702-018-1838-8
Vancouver
Joaquim HPG, Costa AC, Gattaz WF, Talib LL. Kynurenine is correlated with IL-1 beta in plasma of schizophrenia patients [Internet]. Journal of neural transmission. 2018 ; 125( 5): 869-873.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1007/s00702-018-1838-8
Artigo de periodico
Safety limits of antidepressant use plus combinations: focus on cardiovascular function (2018)
Stella, Florindo; Loureiro, Julia C.; Pais, Marcos V.; Canineu, Paulo R.; Forlenza, Orestes Vicente
Source: Current drug metabolism. Unidade: FM
Subjects: SEROTONINA, DOENÇAS CARDIOVASCULARES, ANTIDEPRESSIVOS, PLACEBOS, INFARTO DO MIOCÁRDIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
STELLA, Florindo et al. Safety limits of antidepressant use plus combinations: focus on cardiovascular function. Current drug metabolism, v. 19, n. 8, p. 641-652, 2018Tradução . . Disponível em: https://doi.org/10.2174/1389200219666171227203225. Acesso em: 06 jun. 2024.
APA
Stella, F., Loureiro, J. C., Pais, M. V., Canineu, P. R., & Forlenza, O. V. (2018). Safety limits of antidepressant use plus combinations: focus on cardiovascular function. Current drug metabolism, 19( 8), 641-652. doi:10.2174/1389200219666171227203225
NLM
Stella F, Loureiro JC, Pais MV, Canineu PR, Forlenza OV. Safety limits of antidepressant use plus combinations: focus on cardiovascular function [Internet]. Current drug metabolism. 2018 ; 19( 8): 641-652.[citado 2024 jun. 06 ] Available from: https://doi.org/10.2174/1389200219666171227203225
Vancouver
Stella F, Loureiro JC, Pais MV, Canineu PR, Forlenza OV. Safety limits of antidepressant use plus combinations: focus on cardiovascular function [Internet]. Current drug metabolism. 2018 ; 19( 8): 641-652.[citado 2024 jun. 06 ] Available from: https://doi.org/10.2174/1389200219666171227203225
Artigo de periodico
Increased platelet glycogen sysnthase kinase 3beta in first-episode psychosis (2018)
Joaquim, Helena P. G.; Sallet, Paulo C.; Talib, Leda L; Chaim, Tiffany M; Zanetti, Marcus V.; Serpa, Mauricio H.; Bilt, Martinus T. Van de; Busatto, Geraldo F.; Gattaz, Wagner F.
Source: Schizophrenia research. Unidade: FM
Subjects: ESQUIZOFRENIA, FÁRMACOS PSICOTRÓPICOS, CÓRTEX PRÉ-FRONTAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JOAQUIM, Helena P. G. et al. Increased platelet glycogen sysnthase kinase 3beta in first-episode psychosis. Schizophrenia research, v. 195, p. 402-405, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.schres.2017.08.062. Acesso em: 06 jun. 2024.
APA
Joaquim, H. P. G., Sallet, P. C., Talib, L. L., Chaim, T. M., Zanetti, M. V., Serpa, M. H., et al. (2018). Increased platelet glycogen sysnthase kinase 3beta in first-episode psychosis. Schizophrenia research, 195, 402-405. doi:10.1016/j.schres.2017.08.062
NLM
Joaquim HPG, Sallet PC, Talib LL, Chaim TM, Zanetti MV, Serpa MH, Bilt MTV de, Busatto GF, Gattaz WF. Increased platelet glycogen sysnthase kinase 3beta in first-episode psychosis [Internet]. Schizophrenia research. 2018 ; 195 402-405.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1016/j.schres.2017.08.062
Vancouver
Joaquim HPG, Sallet PC, Talib LL, Chaim TM, Zanetti MV, Serpa MH, Bilt MTV de, Busatto GF, Gattaz WF. Increased platelet glycogen sysnthase kinase 3beta in first-episode psychosis [Internet]. Schizophrenia research. 2018 ; 195 402-405.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1016/j.schres.2017.08.062
Artigo de periodico
Anti-dementia medications: current prescriptions in clinical practice and new agents in progress (2015)
Stella, Florindo; Radanovic, Marcia; Canineu, Paulo Renato; Paula, Vanessa J. R. de; Forlenza, Orestes Vicente
Source: Therapeutic advances in drug safety. Unidade: FM
Subjects: FÁRMACOS PSICOTRÓPICOS, DEMÊNCIA, DOENÇA DE ALZHEIMER, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
STELLA, Florindo et al. Anti-dementia medications: current prescriptions in clinical practice and new agents in progress. Therapeutic advances in drug safety, v. 6, n. 4, p. 151-165, 2015Tradução . . Disponível em: https://doi.org/10.1177/2042098615592116. Acesso em: 06 jun. 2024.
APA
Stella, F., Radanovic, M., Canineu, P. R., Paula, V. J. R. de, & Forlenza, O. V. (2015). Anti-dementia medications: current prescriptions in clinical practice and new agents in progress. Therapeutic advances in drug safety, 6( 4), 151-165. doi:10.1177/2042098615592116
NLM
Stella F, Radanovic M, Canineu PR, Paula VJR de, Forlenza OV. Anti-dementia medications: current prescriptions in clinical practice and new agents in progress [Internet]. Therapeutic advances in drug safety. 2015 ; 6( 4): 151-165.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1177/2042098615592116
Vancouver
Stella F, Radanovic M, Canineu PR, Paula VJR de, Forlenza OV. Anti-dementia medications: current prescriptions in clinical practice and new agents in progress [Internet]. Therapeutic advances in drug safety. 2015 ; 6( 4): 151-165.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1177/2042098615592116

USP Schools

ReP

Filtros

Authors

Subjects

Source title

Countries/Territories

Funding Agencies